DOCSLIB.ORG

The Role of HPV Type in Recurrent Respiratory Papillomatosis.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Role of HPV Type in Recurrent Respiratory Papillomatosis.Pdf International Journal of Pediatric Otorhinolaryngology 74 (2010) 7–14 Contents lists available at ScienceDirect International Journal of Pediatric Otorhinolaryngology journal homepage: www.elsevier.com/locate/ijporl Review article The role of HPV type in Recurrent Respiratory Papillomatosis A.J. Donne a,*, L. Hampson b, J.J. Homer c, I.N. Hampson b a Department of Otolaryngology, Alder Hey Children’s NHS Foundation Trust, Eaton Road, Liverpool, L12 2AP, United Kingdom b University of Manchester Gynaecological Oncology Laboratories, St Mary’s Hospital, Hathersage Road, Manchester, M13 OJH, United Kingdom c Department of Otolaryngology, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, United Kingdom ARTICLE INFO ABSTRACT Article history: Objective: Human Papillomavirus (HPV) 6 and 11 are the aetiological agents responsible for Recurrent Received 20 May 2009 Respiratory Papillomatosis (RRP). There is general consensus that HPV11 results in more aggressive Received in revised form 29 August 2009 disease compared to HPV6. Accepted 3 September 2009 Method: Pubmed was searched using the terms respiratory papillomatosis, HPV 6 and HPV11. Available online 1 October 2009 Comparisons were made in the outcomes of HPV6 versus HPV11 positive RRP disease. Results: There are numerous sub-types or variants of both HPV6 and HPV11. These sub-types have Keywords: different activities at least in-vitro. The numbers of different HPV types within RRP tissue may be more Human Papillomavirus (HPV) extensive than initially appeared. This depends specifically upon the HPV types tested for. HPV6 HPV11 Conclusion: The clinical differences between HPV6 and HPV11 disease may not be accurately predictable Recurrent Respiratory Papillomatosis as these viruses exist in numerous sub-types. Also, RRP tissue may contain more than one subtype or even be co-infected with other viruses that may influence outcome. In-vitro studies upon cell lines are a reasonable starting point for evaluation of these differences. ß 2009 Elsevier Ireland Ltd. All rights reserved. Contents 1. Introduction . 7 2. HPV type (number), low and high risk . 8 3. Viral aetiology . 8 4. Dormant commensal HPV and sample testing reliability . 8 5. Structure of Human Papillomavirus . 9 6. HPV E6 and E7 proteins. 10 7. Defining disease severity. 10 7.1. Disease severity defined as high frequency of surgeries. 11 7.2. Disease severity defined as need for tracheostomy. 11 7.3. Disease severity defined as malignant transformation . 11 7.3.1. The sequence of malignant expression. 11 7.3.2. HPV 6 and 11 in malignancy. 11 7.3.3. HPV 11 integration . 12 7.3.4. HPV 16 and 18 oncogenic potential . 12 7.4. Understanding the value of co-infection . 12 8. Conclusion....................................................................................................... 12 References....................................................................................................... 12 1. Introduction tract. It is caused by the so called ‘‘low risk’’ Human Papillomavirus (HPV) types 6 and 11. Contemporary opinion amongst otolar- Recurrent Respiratory Papillomatosis (RRP) is a disease in yngologists is that HPV 11 related disease is more aggressive than which squamous wart-like lesions occur within the respiratory HPV 6 [1] although this is not universally supported by the published data. If there were HPV type related differences in the * Corresponding author. severity of RRP, this would indicate that optimum choice of E-mail address: [email protected] (A.J. Donne). therapy could be dependent on the HPV type that is present. 0165-5876/$ – see front matter ß 2009 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.ijporl.2009.09.004 8 A.J. Donne et al. / International Journal of Pediatric Otorhinolaryngology 74 (2010) 7–14 However, this is not a simple problem since the prevalence of HPV of these variants confirmed differences between them as great as in both dormant pre-clinical and clinical conditions is variable and 190 fold [17]. In clinical terms, it is difficult to functionally link a the influence of co-infection with other HPV types has not been change in the LCR to viral pathogenesis although it is clear that this fully evaluated. can alter the activity of high-risk HPVs in cervical tumours [18] and low-risk HPV in condyloma accuminata and Buschke–Lowenstein 2. HPV type (number), low and high risk tumours [19]. Yet interestingly, a genetic nucleotide duplication within HPV11 has been identified that may potentially indicate a The Human Papillomavirus (HPV) family are small double more severe disease process in RRP [7]. stranded DNA viruses of approximately 8 Kb in size. HPV is a non- By the use of highly sensitive SYBR-green real-time PCR, HPV encapsulated virus with an icosahedral structure formed by 72 has been found in 100% of papillomas from RRP patients [20].Itis capsomeres. It affects characteristic regions of the body as a result clear that the sensitivity of technique used for HPV detection is of its predisposition for the stratified epithelium of either relevant although it is also important to analyse the viral sub type, cutaneous or mucosal surface. HPV infection therefore results in plus any variants that may be present. Seven different HPV sub- either clinically subtle commensal infection or papilloma (wart) types have been identified from papilloma tissue from RRP patients formation. The latter typically results in warts in the anogenital of which 28/47 cases were HPV6 and 11 [21]. One patient had six region (Condylomata acuminata), cutaneous warts, or the papil- and two had five different sub-types of HPV. Indeed others have loma of Recurrent Respiratory Papillomatosis. also shown that multiple HPV types occur in papillomas harvested There are around 130 different HPV types and these are broadly from RRP patients [22]. Furthermore, the viral copy number has characterised into the low risk (benign disease) or high-risk been estimated to be about 102–107 copies per mg of extracted (malignant disease potential) types where risk implies the sample DNA which is considerably higher than is found for HPV potential for malignant transformation. HPV types are classified positive carcinomas of the larynx and pharynx which contain less by genotype which is defined by the sequence of the viral L1 gene than 10 copies per mg of sample DNA. Interestingly HPV DNA copy [2]. The L1 region encodes for the major capsid protein and number seems to vary by several orders of magnitude during the demonstrates the greatest conservation. It is therefore best suited course of the disease [12] which, to some extent, could account for to construction of the family taxonomy [3]. The major HPV types the difficulty in detecting HPV DNA. Clearly this variance in HPV differ from each other by at least 10% [4] and each HPV type copy number could be prognostically important although the contains within it a family of ‘‘variants’’ that are characterised by relatively low numbers involved do not permit this type of differences in nucleotide sequence of approximately 2% in analysis. (See Table 1 for summary of proportions of RRP samples conserved and 5% in less conserved regions [4]. ‘‘Species’’ is a confirmed to contain HPV). term reserved for phylogenetic associations of different HPV types within a genus that demonstrates 60–70% sequence identity and 4. Dormant commensal HPV and sample testing reliability considerable biological similarity, such as HPV 6 and HPV 11 [5]. The prevalence of HPV in the normal larynx/respiratory tree is 3. Viral aetiology clearly difficult to gauge as this requires ethical approval to biopsy persons with no coincidental pathology and it would be difficult to In 1923 Ullmann originally confirmed the presence of an gain approval for such a study. A UK autopsy study of apparently infectious agent by injecting an extract of a laryngeal papilloma normal larynges, combined with oral sampling, indicated that 25% into his arm with the resultant development of papillomata [6]. may be HPV positive with 3/25 being positive for HPV 11 [23]. Subsequently it has been established that HPV is the causative Consequently, there has been a reliance on oral sampling to agent with the majority of studies demonstrating that either HPV6 measure prevalence, as this is more acceptable. However, even and/or HPV11 are present in most cases of RRP: 98% [7], 83% [8], with this anatomical site there is considerable variation in results 100% [9], 50% [10,11], 100% [12]. The observed differences in depending on the method of tissue sampling. A 3% sucrose detection rate are most likely related to the method of HPV DNA mouthwash versus three separate site buccal mucosal scrapes detection used. For example, Pignatari initially performed in-situ versus buccal mucosal biopsy in the same patient revealed 51%, 45% hybridisation and found HPV in 50% [13]. However, further studies and 12% HPV positive results [24]. The importance of these data is using PCR based techniques, detected HPV in 100% of cases [14].In the low figure obtained with biopsy which arguably should give 1982 Mounts identified only 20% to be positive but this work only the most reliable results. One interpretation of this could be that used HPV6 DNA probes [11]. Interestingly, the value of this report not all cells contain HPV and as the two former methods sample a was that it identified four different sub-types of HPV6 (HPV6c– larger area of mucosa they are more likely to be informative. In this HPV6f) by restriction endonuclease digestion analysis. The series 14% were HPV 6/11 positive and 26% were HPV 16 and/or 18 importance of this observation is that the variation in the positive. On meta-analysis 10% of normal oral mucosa has been effectiveness of RRP therapies could be in part due to possible found to contain high-risk HPV [25]. However, some individual differences in virulence of the different sub-types. Supporting reports were as high as 55% positive for HPV 16/18 which may be evidence comes from the observation that HPV16 E6 variants do associated with geographical differences [26].
Load more

Recommended publications
  • Idiopathic CD4 Lymphocytopenia: Spectrum of Opportunistic Infections, Malignancies, and Autoimmune Diseases
    Published online: 2021-08-09 REVIEW ARTICLE Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases Dina S. Ahmad, Mohammad Esmadi, William C. Steinmann Department of Internal Medicine, University of Missouri School of Medicine, Columbia, MO, USA Access this article online ABSTRACT Website: www.avicennajmed.com DOI: 10.4103/2231-0770.114121 Idiopathic CD4 lymphocytopenia (ICL) was first defined in 1992 by the US Centers for Disease Quick Response Code: Control and Prevention (CDC) as the repeated presence of a CD4+ T lymphocyte count of fewer than 300 cells per cubic millimeter or of less than 20% of total T cells with no evidence of human immunodeficiency virus (HIV) infection and no condition that might cause depressed CD4 counts. Most of our knowledge about ICL comes from scattered case reports. The aim of this study was to collect comprehensive data from the previously published cases to understand the characteristics of this rare condition. We searched the PubMed database and Science Direct for case reports since 1989 for Idiopathic CD4 lymphocytopenia cases. We found 258 cases diagnosed with ICL in 143 published papers. We collected data about age, sex, pathogens, site of infections, CD4 count, CD8 count, CD4:CD8 ratio, presence of HIV risk factors, malignancies, autoimmune diseases and whether the patients survived or died. The mean age at diagnosis of first opportunistic infection (or ICL if no opportunistic infection reported) was 40.7 ± 19.2 years (standard deviation), with a range of 1 to 85. One-sixty (62%) patients were males, 91 (35.2%) were females, and 7 (2.7%) patients were not identified whether males or females.
    [Show full text]
  • Recurrent Respiratory Papillomatosis Or Laryngeal Papillomatosis
    U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES ∙ National Institutes of Health NIDCD Fact Sheet | Voice, Speech, and Language Recurrent Respiratory Papillomatosis or Laryngeal Papillomatosis What is recurrent respiratory papillomatosis? Recurrent respiratory papillomatosis (RRP) is a disease in which benign (noncancerous) tumors called papillomas grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). Although the tumors can grow anywhere in the respiratory tract, they most commonly grow in the larynx (voice box)—a condition called laryngeal papillomatosis. The papillomas may vary in size and grow very quickly. They often grow back after they have been removed. What causes RRP? RRP is caused by two types of human papilloma virus (HPV): HPV 6 and HPV 11. There are more than 150 types of HPV, and they do not all have the same symptoms. Most people who encounter HPV never develop a related illness. However, in a small number of people exposed to the HPV 6 or 11 virus, respiratory tract papillomas and genital warts can form. Although scientists do not fully understand why some people develop the disease and others do not, the virus is thought to be spread through sexual contact or when a mother with genital warts passes the HPV 6 or 11 virus to her baby during childbirth. Who is affected by RRP? RRP may occur in adults (adult-onset RRP) as well as in Parts of the respiratory tract affected by RRP infants and small children (juvenile-onset RRP) who may Source: NIH/NIDCD have contracted the virus during childbirth.
    [Show full text]
  • Enhancing Male HPV Vaccine Acceptance: the Role of Altruism and Awareness of Male Specific Health Benefits
    Syracuse University SURFACE Psychology - Theses College of Arts and Sciences 6-2012 Enhancing Male HPV Vaccine Acceptance: The Role of Altruism and Awareness of Male Specific Health Benefits Katherine Bonafide Syracuse University Follow this and additional works at: https://surface.syr.edu/psy_thesis Part of the Psychology Commons, and the Public Health Commons Recommended Citation Bonafide, Katherine, "Enhancing Male HPV accineV Acceptance: The Role of Altruism and Awareness of Male Specific Health Benefits" (2012). Psychology - Theses. 3. https://surface.syr.edu/psy_thesis/3 This Thesis is brought to you for free and open access by the College of Arts and Sciences at SURFACE. It has been accepted for inclusion in Psychology - Theses by an authorized administrator of SURFACE. For more information, please contact [email protected]. Abstract While considerable research exists on female HPV vaccine acceptance, research is needed to clarify factors that facilitate vaccine uptake among boys and men. The benefits of male HPV vaccination exist on an individual and community level. Male HPV vaccination provides personal health protection to recipients, and can provide female health protection by minimizing transmission of HPV to sexual partners. As such, male vaccine acceptance may be enhanced by emphasizing both altruistic motives (female health protection) and personal health benefits. A sample of college-age men ( N = 200; M age = 19.3; 31% Non-White) completed computer- administered surveys and were presented with one of four informational interventions that varied in the inclusion or exclusion of altruistic motives and in terms of the extent to which male specific HPV-related illnesses and vaccine benefits were stressed.
    [Show full text]
  • Local Application of Cidofovir As an Adjuvant Therapy
    Artigo Original APLicAÇÃO LOCAL DE ciDOFOVIR COMO TRATAMENTO ADJUVANTE NA PAPILOMATOSE LARÍNGEA RECORRENTE EM CRIANÇAS PAULO PONTES1, LUC L. M. WECKX2, SHIRLEY S. N. PIGNATARI3, REGINALDO R. FUJITA4, MELISSA A. G. AVELINO5, JULIANA SATO6* Trabalho realizado na Disciplina de Otorrinolaringologia Pediátrica - Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço da Universidade Federal de São Paulo – UNIFESP, S.Paulo, SP RESUMO OBJETIVO. Avaliar a eficácia da aplicação local de cidofovir em associação com o tratamento cirúrgico na papilomatose laríngea recorrente (PLR) em crianças. Desenho do estudo: Prospectivo. MÉTODOS. Quatorze pacientes, com idade média de 4.7 anos e com duas ou mais recidivas após tratamento cirúrgico, foram submetidos à ressecção dos papilomas e injeção de 22.5 mg de cidofovir (7,5 mg/ml) no tecido de onde as lesões foram removidas. Após intervalos de 2-3 semanas, a mesma dose de cidofovir foi repetida duas ou três vezes. Em caso de recidiva, um novo ciclo de cirurgia seguido de aplicações locais de cidofovir era reiniciado. Cinco crianças apresentavam HPV-6 e cinco HPV-11; em quatro casos a tipagem não foi realizada. RESULTADOS. Antes do início do estudo, os pacientes eram submetidos, em média, a duas cirurgias por ano para o controle das recidivas; após o tratamento com cidofovir, a taxa anual de cirurgia diminuiu para 1,1 (p = 0,013). O intervalo médio entre as recidivas antes do início do estudo era de 1.6 meses; ao final do estudo, o intervalo aumentou para 4,4 meses (p = 0,014). Os pacientes com HPV-6 não apresentaram alteração significante nos intervalos entre as recidivas após o tratamento com cidofovir, *Correspondência: enquanto 60% das crianças com HPV-11 encontravam-se livres de doença ao final do estudo.
    [Show full text]
  • Recurrent Respiratory Papillomatosis: a Report of Two Cases
    Niger J Paed 2014; 41 (1):70 –73 CASE REPORT Ahmed PA Recurrent Respiratory Ulonnam CC Papillomatosis: A Report of two Undie N B cases and review of literature DOI:http://dx.doi.org/10.4314/njp.v41i1,13 Accepted: 3rd September 2013 Abstract Background: Recurrent total obliteration of air column ( ) Respiratory Papillomatosis (RRP) with histological confirmation of Ahmed PA is a non-cancerous tumour of the squamous papilloma. She had Ulonnam CC Department of Paediatrics, upper airway caused by the eight excision surgeries within a human papilloma virus, present- two years period with treatment Undie NB ing as “wart-like” growth, which with oral acyclovir, interferon, and Department of Otorhinolaryngology, could be anywhere from the nose methotrexate and tracheotomy National Hospital Abuja. to the lungs commonly in the lar- tube in situ. Case two, a six year Nigeria. ynx. old female presented with persis- Email: [email protected] Design and Setting: Review of tent hoarseness of voice that pro- two cases at the National Hospital gressed to loss of voice, noisy and Abuja (NHA). difficulty in breathing, snoring and Objectives: To highlight the chal- frequent arousal from sleep of 1½ lenges in the management of years. Histology was diagnostic of RRP. laryngeal Papillomatosis and she Subjects: Two patients diagnosed had two excisions surgeries and with RRP were referred to the treatment with oral acyclovir and paediatric respiratory clinic be- tracheotomy tube in place. tween 2009 and 2012. Case one is Conclusion: RRP though a slow a four year old female who pre- growing tumour, presently has no sented with persistent hoarseness definitive cure.
    [Show full text]
  • Herpes Simplex Virus-2 Associated with a Large Fungating Penile Mass
    Urology Case Reports 36 (2021) 101594 Contents lists available at ScienceDirect Urology Case Reports journal homepage: http://www.elsevier.com/locate/eucr Inflammation and infection Herpes simplex virus-2 associated with a large fungating penile mass Max S. Bowman a,*, Ursula E. Lang b, Kieron S. Leslie c, Gregory Amend a, Benjamin N. Breyer d a Department of Urology, University of California, San Francisco, Department of Urology, 400 Parnassus Ave, San Francisco, CA, 94143, USA b Department of Pathology, Zuckerberg San Francisco General Hospital and University of California, San Francisco, 1001 Potrero Ave, San Francisco, CA, 94110, USA c Department of Dermatology, Zuckerberg San Francisco General Hospital, 1001 Potrero Ave, San Francisco, CA, 94110, USA d Department of Urology, Zuckerberg San Francisco General Hospital and University of California, San Francisco 400 Parnassus Ave, San Francisco, CA, 94143, USA ARTICLE INFO ABSTRACT Keywords: A 48-year-old male with HIV/AIDS presented with an enlarging nodular lesion on the base of his penis. Histology HIV revealed changes consistent with chronic viral infection and culture grew herpes simplex virus 2 (HSV-2). The Herpes lesion was refractory to valacyclovir and intralesional (IL) cidofovir therapy. Urology excised the mass and the Reconstructive urology defect was repaired primarily with good cosmetic result. Post-operative pathology confirmed HSV-2 despite the Infectious disease unusual appearance of the lesion consisting of nodular mass without gross ulceration. Genital lesion Introduction milligrams for three total injections was initiated. Despite this, the mass grew larger and he was referred to Urology for excision. Preoperative Classic herpes simplex virus 2 (HSV-2) lesions produce painful gen­ exam revealed a 4 × 2cm exophytic nodule at the dorsal base of his penis ital ulcers.
    [Show full text]
  • Epidemiology of Recurrent Respiratory Papillomatosis
    APMIS 118: 450–454 Ó 2010 The Authors Journal Compilation Ó 2010 APMIS DOI 10.1111/j.1600-0463.2010.02619.x Epidemiology of recurrent respiratory papillomatosis DANIEL A. LARSON and CRAIG S. DERKAY Department of Otolaryngology ⁄ Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS 2010; 118: 450–454. Recurrent respiratory papillomatosis (RRP) was first described in the 1800s, but it was not until the 1980s when it was convincingly attributed to human papilloma virus (HPV). RRP is categorized into juvenile onset and adult onset depending on presentation before or after the age of 12 years, respec- tively. The prevalence of this disease is likely variable depending on the age of presentation, country and socioeconomic status of the population being studied, but is generally accepted to be between 1 and 4 per 100 000. Despite the low prevalence, the economic burden of RRP is high given the multiple procedures required by patients. Multiple studies have shown that the most likely route of transmission of HPV in RRP is from mother to child during labor. Exceptions to this may include patients with con- genital RRP who have been exposed in utero and adult patients who may have been exposed during sexual contact. Although cesarean section may prevent the exposure of children to the HPV virus dur- ing childbirth, its effectiveness in preventing RRP is debatable and the procedure itself carries an increased risk of complications. The quadrivalent HPV vaccine holds the most promise for the preven- tion of RRP by eliminating the maternal reservoir for HPV.
    [Show full text]
  • ENT Infections: an Atlas of Investigation and Management
    An Atlas of Investigation and Management Paleri • Hill An Atlas of Investigation and Management ENT INFECTIONS ENT INFECTIONS An illustrated guide to the investigation, diagnosis and management of infectious diseases of the ear, nose and throat. The authors lead the reader through physical Vinidh Paleri • John Hill examination followed by an overview of the microbiology of ENT infections, describing the main infective organisms and the tests by which the presence of bacterial, viral, fungal and other infections can be confirmed. This is followed by a brief summary of the principles of pharmacological management, the agents currently in use and their mode of action. The ensuing sections of the atlas focus separately on infections of the ear, the nose and paranasal sinuses, the mouth, the pharynx, the larynx and the neck. All chapters present an illustrated discussion of relevant infections, covering various possible diagnoses, the causative organisms and the means by which the infection can be ENT INFECTIONS ENT treated. Information is supported by high quality colour photographs, diagnostic algorithms and tables throughout. The concluding chapter deals with some of the most important tropical infections which are encountered with increasing frequency and with which the clinician needs to be familiar. Related title: Problem Solving in Infection, S Dancer, A Seaton ISBN 978 1 904392 83 5 Website: www.clinicalpublishing.co.uk ISBN: 978 1 84692 006 6 Barcode Scaled PUBLISHING CLINICAL CLINICAL PUBLISHING ENT Infections CMYK ENT Final.qxd:Dementia final.qxd 12/2/10 06:23 Page ii Dedication This book is dedicated to the memory of both our fathers.
    [Show full text]
  • Hpv- Related Oral Lesions- a Review
    JOURNAL OF CRITICAL REVIEWS ISSN- 2394-5125 VOL 7, ISSUE 14, 2020 HPV- RELATED ORAL LESIONS- A REVIEW Nishanth.G 1, Aravindha Babu.N 2, N.Anitha3, L.Malathi3 1Post Graduate student, Sree Balaji Dental College and Hospital , Bharath Institute of Higher Education ( BIHER) Chennai 2Professor, Sree Balaji Dental College and Hospital , Bharath Institute of Higher Education ( BIHER) Chennai 3Reader, Sree Balaji Dental College and Hospital , Bharath Institute of Higher Education ( BIHER) Chennai Received: 14 March 2020 Revised and Accepted: 8 July 2020 ABSTRACT: Human papillomavirus (HPV) includes the majority of newly acquired sexually transmitted infections (STIs). Genital HPV is the most common STI with incidence of about 5.5 million world‑wide, nearly 75% of sexually active men and women have been exposed to HPV at some point in their lives. Oral Sexual behavior is an important and contributing factor to infection of HPV in the oral mucosa especially in cases known to practice high risk behavior and initiating the same at an early age. HPV infection of the oral mucosa in the current concept is believed to affect 1‑50% of the general population, depending on the methods which are used for diagnosis. The immune system clears most HPV naturally within 2 years (about 90%), but the ones that persist can cause serious diseases. HPV is an essential carcinogen being implicated increasingly in association with cancers occurring at numerous sites in the body. Though there does not occur any specific treatment for the HPV infection, the diseases it causes are treatable such as genital warts, cervical and other cancers.
    [Show full text]
  • World Journal of Radiology
    World Journal of W J R Radiology Online Submissions: http://www.wjgnet.com/1949-8470office World J Radiol 2011 December 28; 3(12): 279-288 [email protected] ISSN 1949-8470 (online) doi:10.4329/wjr.v3.i12.279 © 2011 Baishideng. All rights reserved. EDITORIAL Chest neoplasms with infectious etiologies Carlos S Restrepo, Melissa M Chen, Santiago Martinez-Jimenez, Jorge Carrillo, Catalina Restrepo Carlos S Restrepo, Melissa M Chen, Santiago Martinez- Peer reviewer: Patrick K Ha, MD, Assistant Professor, Johns Jimenez, Jorge Carrillo, Catalina Restrepo, Department of Hopkins Department of Otolaryngology, Johns Hopkins Head Radiology, The University of Texas Health Science Center at San and Neck Surgery at GBMC, 1550 Orleans Street, David H Koch Antonio, Mail Code 7800, 7703 Floyd Curl Drive, San Antonio, Cancer Research Building, Room 5M06, Baltimore, MD 21231, TX 78229, United States United States Author contributions: Chen MM, Restrep CS reviewed and summarized the literature that provided the basis of the manu- Restrepo CS, Chen MM, Martinez-Jimenez S, Carrillo J, Re- script. Martinez-Jimenez C, Carrillo J and Restrepo C contributed strepo C. Chest neoplasms with infectious etiologies. World J to the conceptual design of the manuscript and data interpretation. Radiol 2011; 3(12): 279-288 Available from: URL: http://www. Correspondence to:��������������������� Carlos S Restrepo, M������������, Assistant ����ro- wjgnet.com/1949-8470/full/v3/i12/279.htm DOI: http://dx.doi. fessor, Department of Radiology, The University of Texas Health org/10.4329/wjr.v3.i12.279 Science Center at San Antonio, Mail Code 7800, 7703 Floyd Curl Drive, San Antonio, TX 78229, United States.
    [Show full text]
  • RRP Reference Service Fall 08
    RRP Medical Reference Service An RRP Foundation Publication edited by Dave Wunrow and Bill Stern Fall 2008 ___________________ Volume 15 • Number 1 Preface The RRP Medical Reference Service is intended to be of potential interest to RRP patients/families seeking treatment, practitioners providing care, micro biological researchers as well as others interested in developing a comprehensive understanding of recurrent respiratory papillomatosis. This issue focuses on a selection of references with abstracts from recent (2008 and later) RRP related publications.These listings are sorted in approximate reverse chronological order as indicated by the "PMID" numbers. Each listing is formatted as follows: Journal or reference Title Language (if it is not specified assume article is in English) Author(s) Primary affiliation (when specified) Abstract PMID (PubMed ID) If copies of complete articles are desired, we suggest that you request a reprint from one of the authors. If you need assistance in this regard or if you have any other questions or comments please feel free to contact: Bill Stern RRP Foundation P.O. Box 6643 Lawrenceville NJ 08648-0643 (609) 530-1443 or (609)452-6545 E-mail: [email protected] David Wunrow RPh. 210 Columbus Drive Marshfield WI 54449 (715) 387-8824 E-mail: [email protected] RRPF Selected Articles and Abstracts Curr Opin Otolaryngol Head Neck Surg. 2008 Dec;16(6):536-542. Recurrent respiratory papillomatosis: update 2008. Gallagher TQ, Derkay CS. aDepartment of Otolaryngology - Head and Neck Surgery, Naval Medical Center, Portsmouth, USA bDepartment of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, USA cDepartment of Pediatrics, Eastern Virginia Medical School, Norfolk, Virginia, USA.
    [Show full text]
  • Summaries Schroten/Wirth: Pediatric Infectious Diseases Revisited
    Summaries Schroten/Wirth: Pediatric Infectious Diseases Revisited Summary Rudolf H. Tangermann, Hanna Nohynek and Rudolf Eggers Global control of infectious diseases by vaccination programs In both industrialized and developing countries, childhood immunization has become one of the most important and cost-effective public health interventions. National immunization programmes have prevented millions of deaths since WHO initiated the ‘Expanded Programme on Immunization (EPI)’ in 1974. Smallpox was eradicated in 1979, poliomyelitis is on the verge of eradication, and 2/3 of developing countries have eliminated neonatal tetanus. Global immunization coverage was at 78% in 2004. Through their impact on childhood morbidity and mortality, immunization programmes are contributing to reaching the ‘Millenium Development Goal 4’ – a 2/3 reduction of under-five mortality by 2015. However, the failure to reach > 20% of the world's children with existing vaccines was responsible for at least 2.5 million of an estimated 10.5 million deaths of children < 5 years, mainly in developing countries. Of these deaths, 1.4 million could have been prevented by vaccines currently recommended by WHO. Rapid progress in understanding of infectious disease pathogenesis, immunology, and biotechnology has increased the number of candidate vaccine antigens available. Pressures are growing on public health decision makers to establish evidence-based ways to decide which new vaccines should be introduced on large scale into national immunization programmes. The gap in access to new vaccines between the developing and industrialized world is still wide, and wealthy countries are still the first to introduce and use new vaccines. Interest from countries and partner agencies in vaccination, as one of the most cost-effective public health interventions, continues to be strong, also due to rapid progress in biotechnology and vaccine development and the emergence of global infectious disease threats, including HIV/AIDS, SARS, and influenza.
    [Show full text]